Evidence map›Paper›PMID 20178130›Full record

ArticleArthritis and rheumatism2010

Induction of CD44 cleavage in articular chondrocytes.

Nobunori Takahashi, Cheryl B Knudson, Sai Thankamony, Wataru Ariyoshi, Liliana Mellor, Hee-Jeong Im, Warren Knudson

Abstract read
In one paragraph

Article in Arthritis and rheumatism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Suppression of murine osteoarthritis by 4-methylumbelliferone.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Article
  9. Article
  10. Article
  11. The pericellular hyaluronan of articular chondrocytes.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. CD44 knock-down in bovine and human chondrocytes results in release of bound HYAL2.Matrix biology : journal of the International Society for Matrix Biology · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nobunori TakahashiThe Brody School of Medicine, East Carolina University, Greenville, North Carolina 27834-4354, USA.
Cheryl B Knudson
Sai Thankamony
Wataru Ariyoshi
Liliana Mellor
Hee-Jeong Im
Warren Knudson
East Carolina University · USRush University Medical Center · US

Funding

HYALURONAN-CELL INTERACTIONS IN CARTILAGER01AR039507 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI KNUDSON, CHERYL B · 1998 to 2013
$3.1M
CD44 MEDIATED CATABOLISM OF HYALURONAN BY CHONDROCYTESR01AR043384 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI KNUDSON, WARREN · 1996 to 2009
$2.7M
Pathological Role of bFGF in Human Adult Articular CartilageR01AR053220 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI SAMPEN, HEE-JEONG IM · 2006 to 2010
$1.6M
OSTEOARTHRITIS AND KNEE JOINT PAINI01BX002647 · VA · JESSE BROWN VA MEDICAL CENTER · PI SAMPEN, HEE-JEONG IM · 2015 to 2023
–
BLRD VA I01 BX002647NIAMS NIH HHS R01 AR039507NIAMS NIH HHS R01 AR043384NIAMS NIH HHS R01 AR053220NIAMS NIH HHS R01-AR-053220NIAMS NIH HHS R01-AR-39507NIAMS NIH HHS R01-AR-43384
6 · The paper itself

Abstract

objectiveThe hyaluronan receptor CD44 provides chondrocytes with a mechanism for sensing and responding to changes in the extracellular matrix. The purpose of this study was to document the fragmentation and loss of CD44 and to determine the likely mechanisms involved.

methodsA polyclonal anti-CD44 cytotail antibody was generated to detect CD44 fragmentation by Western blot analysis. Chondrocytes were isolated from human or bovine articular cartilage. Primary articular chondrocytes were treated with interleukin-1beta (IL-1beta), hyaluronan oligosaccharides, or phorbol myristate acetate or were passaged and subcultured in monolayer to induce dedifferentiation. Conditions that altered the capacity of CD44 to transit into lipid rafts, or pharmacologic inhibitors of metalloproteinase or gamma-secretase activity were used to define the mechanism of fragmentation of CD44.

resultsChondrocytes from osteoarthritic cartilage exhibited CD44 fragmentation as low molecular mass bands, corresponding to the CD44-EXT and CD44-ICD bands. Following dedifferentiation of chondrocytes or treatment of primary chondrocytes with hyaluronan oligosaccharides, IL-1beta, or phorbol myristate acetate, CD44 fragmentation was enhanced. Subsequent culture of the dedifferentiated chondrocytes in 3-dimensional alginate beads rescued the chondrocyte phenotype and diminished the fragmentation of CD44. Fragmentation of CD44 in chondrocytes was blocked in the presence of the metalloproteinase inhibitor GM6001 and the gamma-secretase inhibitor DAPT.

conclusionCD44 fragmentation, consistent with a signature pattern reported for sequential metalloproteinase/gamma-secretase cleavage of CD44, is a common metabolic feature of chondrocytes that have undergone dedifferentiation in vitro and osteoarthritic chondrocytes. Transit of CD44 into lipid rafts may be required for its fragmentation.

Indexed as

Adjuvants, ImmunologicAmyloid Precursor Protein SecretasesAnimalsAntibodiesCarcinogensCattleCell DifferentiationCells, CulturedChlorocebus aethiopsChondrocytesCOS CellsDipeptidesExtracellular MatrixHumansHyaluronan ReceptorsHyaluronic AcidAdjuvants, ImmunologicAmyloid Precursor Protein SecretasesAntibodiesCarcinogensCD44 protein, humanDipeptidesHyaluronan ReceptorsHyaluronic AcidInterleukin-1betaMetalloproteasesN-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamidePeptide FragmentsProtease InhibitorsTetradecanoylphorbol Acetate

Identifiers

PMID20178130
PMCPMC2896278
OpenAlexW1963764033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.